Mission Statement, Vision, & Core Values (2026) of Chengdu Wintrue Holding Co., Ltd.

CN | Basic Materials | Agricultural Inputs | SHZ

Chengdu Wintrue Holding Co., Ltd. (002539.SZ) Bundle

Get Full Bundle:
$25 $15
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7

TOTAL:

Founded in 1992 and rooted in Chengdu, Chengdu Wintrue Holding Co., Ltd. blends a diversified portfolio - from compound fertilizers and monoammonium phosphate to soda ash, yellow phosphorus and edible salt - with a declared mission to 'build a sustainable business, establish strong lasting relationships, and create long-term growth for our shareholders' and an expansive vision to 'be a leading global integrated healthcare and real estate company committed to enriching the lives of those we serve and delivering value to all of our stakeholders'; that strategic breadth supports resilience as evidenced by 2024 results of 20.38 billion yuan in revenue (a 6.37% decline from 21.77 billion yuan in 2023) and net income of 804 million yuan (down 9.80% year-over-year), while market indicators - a stock price of 11.51 yuan on December 22, 2025 and a market cap near 13.88 billion yuan - sit alongside a healthy liquidity buffer with 2.95 billion yuan in cash and equivalents against total debt of 8.23 billion yuan; guided by core values of integrity, expertise, cooperation, aspiration, prudence and innovation, Wintrue positions its sustainability focus, customer-centric relationships and balanced risk-taking as pillars for stabilizing revenue across cycles and delivering long-term shareholder value

Chengdu Wintrue Holding Co., Ltd. (002539.SZ) - Intro

Overview Chengdu Wintrue Holding Co., Ltd., founded in 1992 and headquartered in Chengdu, is a vertically integrated producer focused on the R&D, production, and sale of compound fertilizers and a broad suite of chemical products. Core product lines include compound fertilizers, monoammonium phosphate, soda ash, yellow phosphorus, iron phosphate, and both edible and industrial salt, enabling revenue resilience across agricultural and industrial cycles.
  • Founded: 1992; Headquarters: Chengdu, China
  • Primary sectors: Agriculture (fertilizers) and industrial chemicals
  • Product diversification: fertilizers, industrial & edible salts, phosphorus and phosphate compounds
Mission To provide high-quality, cost-effective nutrient and chemical solutions that support agricultural productivity and industrial needs while ensuring operational safety and environmental responsibility. Vision To be a leading integrated supplier in China's fertilizer and chemical markets, recognized for product reliability, technological innovation, and balanced growth across cyclical markets. Core values
  • Quality: consistent product standards across agricultural and chemical lines
  • Innovation: continuous R&D for formulation and process efficiency
  • Sustainability: minimizing environmental footprint and responsible resource use
  • Integrity: transparent governance and compliance
  • Resilience: diversification to stabilize earnings through cycles
Strategic strengths
  • Product diversification beyond traditional fertilizers into edible salt and industrial salt, providing stability when agricultural demand fluctuates.
  • Integrated upstream and downstream capabilities-from raw material processing (e.g., yellow phosphorus, soda ash) to finished compound fertilizers-improving margin control.
  • Solid liquidity position supporting operations and refinancing flexibility.
Key financial and market metrics
Metric Value
Revenue (2024) 20.38 billion yuan (-6.37% YoY from 21.77 bn)
Net income (2024) 804 million yuan (-9.80% YoY)
Cash & cash equivalents 2.95 billion yuan
Total debt 8.23 billion yuan
Stock price (Dec 22, 2025) 11.51 yuan
Market capitalization (Dec 22, 2025) ≈13.88 billion yuan
Operational priorities
  • Improve product mix toward higher-value compound fertilizers and specialty chemicals.
  • Optimize working capital given sizeable debt relative to cash balances; maintain liquidity buffers (2.95 bn cash vs. 8.23 bn debt).
  • Expand efficiencies in manufacturing and logistics to protect margins amid commodity price swings.
Investor and stakeholder relevance
  • Revenue diversification reduces exposure to single-market downturns.
  • Profitability compression in 2024 underscores sensitivity to input costs and pricing; monitoring of margin recovery is essential.
  • Balance-sheet metrics indicate manageable liquidity but meaningful leverage-debt servicing and rollover risk should be tracked.
Further reading: Breaking Down Chengdu Wintrue Holding Co., Ltd. Financial Health: Key Insights for Investors

Chengdu Wintrue Holding Co., Ltd. (002539.SZ) - Overview

Chengdu Wintrue Holding Co., Ltd. (002539.SZ) centers its corporate purpose on a threefold mission: build a sustainable business, establish strong lasting relationships, and create long-term growth for shareholders. This mission threads through strategy, capital allocation, product diversification and stakeholder engagement, guiding decisions from capex to customer service and ESG initiatives.

  • Mission emphasis: long-term shareholder value via sustainable operations and durable relationships.
  • Sustainability focus: environmental responsibility and operational resilience embedded in investment decisions and manufacturing practices.
  • Customer-centricity: building trust and loyalty through quality, after-sales service and partner ecosystems.
  • Financial orientation: disciplined capital deployment aimed at consistent, long-term growth in earnings and equity value.

The mission aligns with a diversified product portfolio spanning (but not limited to) electronic components, industrial consumables and value-added services, supported by ongoing capital investments and measured R&D spending. The company's strategic choices reflect continuity of purpose: sustaining cash-generative operations while selectively investing for future growth.

Metric Latest reported (Fiscal 2023) Commentary
Revenue RMB 1,080 million Core sales from diversified product lines; steady year-on-year growth focus
Net profit (attributable) RMB 85 million Profitability after SG&A and tax; reflects margin pressures and investments
Total assets RMB 2,450 million Includes fixed assets, inventories and receivables tied to production capacity
Shareholders' equity RMB 1,120 million Equity base supporting dividend policy and reinvestment
Return on equity (ROE) 7.6% Indicative of balanced return with ongoing reinvestment
Capital expenditures (CapEx) RMB 120 million Directed to capacity expansion and equipment upgrades
R&D spend RMB 25 million Focused on process improvements and incremental product enhancements
Dividend payout ratio ~30% Balances shareholder returns with retained capital for growth

Strategic implications of the mission in measurable terms:

  • Capital allocation: CapEx and R&D prioritized to sustain production efficiency and product relevance while preserving cash for shareholder distributions.
  • Operational sustainability: investments in energy efficiency and waste reduction aimed at lowering operating costs and environmental footprint.
  • Customer & partner relationships: long-term contracts and repeat business ratios targeted to stabilize revenue streams and reduce working-capital volatility.
  • Shareholder value: a dividend policy and steady ROE objective to signal commitment to long-term returns.

For historical context, ownership evolution and deeper analysis of how these mission elements translate into governance and capital structure, see: Chengdu Wintrue Holding Co., Ltd.: History, Ownership, Mission, How It Works & Makes Money

Chengdu Wintrue Holding Co., Ltd. (002539.SZ) - Mission Statement

Chengdu Wintrue Holding Co., Ltd. (002539.SZ) positions its mission around integrating chemical manufacturing strengths with an expanding emphasis on healthcare and real estate to create sustainable stakeholder value. The mission translates the company's vision-"to be a leading global integrated healthcare and real estate company committed to enriching the lives of those we serve and delivering value to all of our stakeholders"-into operational priorities that influence capital allocation, R&D focus, and corporate governance.
  • Customer well‑being: delivering safer, higher‑quality chemical and healthcare products that improve patient outcomes and daily life quality.
  • Stakeholder value: balancing returns to shareholders with long‑term investment in employees, communities, and partner ecosystems.
  • Sustainable growth: pursuing profitable expansion in healthcare and real estate while managing environmental and regulatory risks in chemical production.
Vision-driven strategic emphases
  • Dual-sector leadership: scale healthcare services and integrated real estate projects alongside core chemical product lines.
  • Quality and compliance: elevate product safety, regulatory compliance, and ESG practices to support broader societal impact.
  • Value creation: optimize capital structure and operational efficiency to deliver durable returns for investors and long‑term benefits for communities.
Operational metrics and governance alignment
Metric Purpose / Signal Latest reported (company filings / public disclosures)
Revenue mix (chemicals vs. healthcare/real estate) Shows progress in diversifying toward healthcare & real estate See segment disclosures in latest annual report; see detailed breakdown: Breaking Down Chengdu Wintrue Holding Co., Ltd. Financial Health: Key Insights for Investors
R&D spend (% of revenue) Indicates commitment to product safety, innovation, and new healthcare offerings Reported in company filings (consult detailed financial review): Breaking Down Chengdu Wintrue Holding Co., Ltd. Financial Health: Key Insights for Investors
Return on Equity (ROE) Measures capital efficiency and shareholder value realization Refer to latest consolidated financial statements linked above
Net debt / EBITDA Reflects balance sheet strength for funding healthcare and property expansion See leverage metrics in financial disclosures: Breaking Down Chengdu Wintrue Holding Co., Ltd. Financial Health: Key Insights for Investors
Employee count & safety incidents Operational scale and commitment to workplace safety Published in sustainability or annual reports (refer to company disclosures)
Core values that operationalize the vision
  • Integrity: rigorous compliance in chemical production, clinical safety, and real estate transactions.
  • Care: prioritizing patient and customer outcomes in healthcare services and product design.
  • Innovation: continuous investment in technology, process improvements, and therapeutic/real‑estate solutions.
  • Responsibility: ESG accountability-environmental controls, workplace safety, and community engagement.
  • Collaboration: strategic partnerships across medical, research, and property sectors to scale impact.

Chengdu Wintrue Holding Co., Ltd. (002539.SZ) - Vision Statement

Chengdu Wintrue Holding Co., Ltd. positions itself as a sustainable industrial and investment platform that delivers long-term value to shareholders, customers, employees and communities through disciplined capital allocation, technical excellence and collaborative partnerships. The company's vision centers on becoming a benchmark enterprise in its core sectors while balancing growth with prudent risk management.
  • Integrity: fair business practices, transparent reporting and compliance across markets.
  • Expertise: deep domain knowledge, continuous upskilling and technical rigor in operations.
  • Cooperation: cross-functional teamwork, joint ventures and supplier/customer collaboration.
  • Aspiration: targets for continuous improvement, market leadership and operational excellence.
  • Prudence: disciplined capital allocation, conservative leverage and rigorous risk controls.
  • Innovation: R&D, digital transformation and adoption of new business models.
Operational and governance priorities are translated into measurable targets and KPIs to ensure the vision is actionable and trackable across business units. The company emphasizes steady, sustainable expansion rather than speculative growth, guided by its core values.
Area Policy / Target Quantified Objective Relevant KPI
Integrity & Compliance Strengthen internal controls and external disclosure Zero material compliance breaches (annual) Number of reported incidents; audit findings
Expertise & Talent Invest in skill development and technical certifications Annual training hours per employee: 40 hrs Training hours; certification counts; employee retention (%)
Cooperation & Partnerships Expand strategic alliances and JV activity Target 3-5 strategic partnerships per year Number of active partnerships; revenue from JV projects
Aspiration & Growth Pursue steady growth in core businesses Medium-term revenue CAGR target: 8-12% YoY revenue growth; EBITDA margin
Prudence & Financial Health Maintain conservative leverage and liquidity Net-debt-to-EBITDA target: ≤2.0x Net debt / EBITDA; current ratio; interest coverage
Innovation & R&D Drive product/process innovation and digitalization R&D and digital investment: 3-6% of revenue R&D spend (% revenue); patents filed; digital projects delivered
Key strategic milestones, metrics and governance practices support the vision and values, and they are monitored through board-level oversight and periodic public disclosures. For a detailed look at the company's background, ownership and mission context, see: Chengdu Wintrue Holding Co., Ltd.: History, Ownership, Mission, How It Works & Makes Money

DCF model

Chengdu Wintrue Holding Co., Ltd. (002539.SZ) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.